For UTIs and typhoid fever, selecting an effective oral antibiotic is critical for achieving successful outcomes while improving patient convenience. Cefixime, as an oral third-generation cephalosporin, is a versatile treatment option for uncomplicated urinary tract infections, enteric (typhoid) fever, and IV-to-oral switch therapy. With broad-spectrum activity, excellent tissue penetration, high stability against beta-lactamase enzymes, and convenient once-daily dosing, cefixime offers a strong balance of efficacy, safety, and patient adherence.
Explore clinical evidence presented through 3 cases that demonstrates Cefixime’s (Eficef’s) effectiveness, including higher cure rates and better tolerability compared with some commonly used alternatives. The CME module also emphasizes Cefixime’s value as a step-down therapy following IV antibiotics, enabling earlier hospital discharge, lower healthcare costs, and seamless continuation of treatment.